ArticleMolecular biology reports2025
The crucial role of circadian synchronization in bone marrow adipose tissue mesenchymal stem cells: insights into pathogenesis in Fanconi anemia and acute myeloid leukemia.
Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundThe circadian rhythms, intrinsic 24-hour oscillations in physiological and cellular processes, serve as fundamental regulators of cellular function and metabolism. Although these rhythms are robust, they are susceptible to dysregulation, particularly in hematological diseases, where circadian misalignment exacerbates pathological conditions. The role of bone marrow adipose tissue mesenchymal stem cells (BMAT-MSCs), a dynamic component of the bone marrow microenvironment, in the pathogenesis of Fanconi anemia (FA), a genetic disorder characterized by a predisposition to myeloproliferative disease and acute myeloid leukemia (AML), remains poorly understood. This study explores the potential therapeutic applications of dexamethasone (DEX)-induced synchronization in BMAT-MSCs derived from healthy donors (HD), FA, and AML. METHODS AND
resultsBMAT-MSCs were subjected to DEX-induced synchronization to emulate in vivo conditions, after which comprehensive analyses of circadian gene expression, metabolomic and lipidomic profiles were conducted. Synchronization restored PER1 rhythmicity across all groups, indicating effective circadian entrainment, whereas CRY1 rhythms were attenuated in FA and AML. Lipidomic and metabolomic readouts under synchronized conditions showed more consistent, timepoint-aligned patterns than in unsynchronized cells, enabling clearer identification of group-specific alterations, including changes related to phospholipid/lipid remodeling pathways.
conclusionsThese data indicate that circadian synchronization improves interpretability of BMAT-MSC molecular outputs and reveals disease-associated differences among HD, FA, and AML. This study is a preliminary investigation with limited sampling and timepoints; findings should be validated in larger cohorts with denser temporal resolution. Overall, the results provide a framework for integrating circadian context into BMAT-MSC analyses in health and hematological disease.
Indexed as
Identifiers
41236654What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.